Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125533631 | 12553363 | 1 | I | 20151115 | 20160414 | 20160713 | 20160713 | EXP | US-BAYER-2016-100668 | BAYER | 88.00 | YR | E | M | Y | 0.00000 | 20160713 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125533631 | 12553363 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, UNK | Y | N | UNKNOWN | 0 | 15 | MG | FILM-COATED TABLET | ||||
125533631 | 12553363 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
125533631 | 12553363 | 3 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | UNK | Y | UNKNOWN | 999999 | ||||||||
125533631 | 12553363 | 4 | SS | TYLENOL | ACETAMINOPHEN | 1 | Oral | UNK | UNKNOWN | 0 | |||||||||
125533631 | 12553363 | 5 | C | COREG | CARVEDILOL | 1 | Unknown | UNK | 0 | ||||||||||
125533631 | 12553363 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
125533631 | 12553363 | 7 | C | LASIX | FUROSEMIDE | 1 | Unknown | UNK | 0 | ||||||||||
125533631 | 12553363 | 8 | C | NAMENDA | MEMANTINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
125533631 | 12553363 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
125533631 | 12553363 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125533631 | 12553363 | 1 | Thrombosis prophylaxis |
125533631 | 12553363 | 2 | Thrombosis prophylaxis |
125533631 | 12553363 | 3 | Product used for unknown indication |
125533631 | 12553363 | 4 | Product used for unknown indication |
125533631 | 12553363 | 5 | Hypertension |
125533631 | 12553363 | 6 | Hypertension |
125533631 | 12553363 | 7 | Cardiac failure congestive |
125533631 | 12553363 | 8 | Dementia |
125533631 | 12553363 | 9 | Hypothyroidism |
125533631 | 12553363 | 10 | Gastrooesophageal reflux disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125533631 | 12553363 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125533631 | 12553363 | Acute kidney injury | |
125533631 | 12553363 | Anaemia | |
125533631 | 12553363 | Ear haemorrhage | |
125533631 | 12553363 | Internal haemorrhage | |
125533631 | 12553363 | Renal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125533631 | 12553363 | 1 | 201506 | 20151115 | 0 |